Detection of 4 benzodiazepines in oral fluid as biomarker for presence in blood

Therapeutic Drug Monitoring

Volumn 36, Issue 2, 2014, Pages 252-256

  Gjerde, Hallvard ^a   Langel, Kaarina ^b   Favretto, Donata ^c   Verstraete, Alain G ^d  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF PADOVA   (Italy)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Alprazolam; Clonazepam; Diazepam; Nordiazepam; Oral fluid

Indexed keywords

ALPRAZOLAM; BIOLOGICAL MARKER; CLONAZEPAM; DIAZEPAM; NORDAZEPAM; BENZODIAZEPINE DERIVATIVE;

ACCURACY; ARTICLE; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DETERMINATION; DRUG SALIVA LEVEL; DRUG USE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FINLAND; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; NORWAY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SALIVA; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; BLOOD; CHEMISTRY; LABORATORY DIAGNOSIS; PROCEDURES; REPRODUCIBILITY; SUBSTANCE ABUSE;

BENZODIAZEPINES; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; FALSE NEGATIVE REACTIONS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; REPRODUCIBILITY OF RESULTS; SALIVA; SUBSTANCE ABUSE DETECTION;

EID: 84897085665     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3182a3ab42     Document Type: Article

References (38)

1. Samyn N, Verstraete A, van Haeren C, et al. Analysis of drugs of abuse in saliva. Forensic Sci Rev. 1999;11:2-17
2. Choo RE, Huestis MA. Oral fluid as a diagnostic tool. Clin Chem Lab Med. 2004;42:1273-1287
3. Drummer OH. Drug testing in oral fluid. Clin Biochem Rev. 2006;27: 147-159
4. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem. 2009;55:1910-1931
5. Kato K, Hillsgrove M, Weinhold L, et al. Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions. J Anal Toxicol. 1993;17:338-341
6. Schepers RJ, Oyler JM, Joseph RE Jr, et al. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem. 2003;49:121-132
7. O'Neal CL, Crouch DJ, Rollins DE, et al. The effects of collection methods on oral fluid codeine concentrations. J Anal Toxicol. 2000;24: 536-542
8. Crouch DJ. Oral fluid collection: The neglected variable in oral fluid testing. Forensic Sci Int. 2005;150:165-173
9. Houwing S, Smink BE, Legrand SA, et al. Repeatability of oral fluid collection methods for THC measurement. Forensic Sci Int. 2012;223: 266-272
10. Wille SM, Raes E, Lillsunde P, et al. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of DUID. Ther Drug Monit. 2009;31:511-519
11. Gjerde H, Mordal J, Christophersen AS, et al. Comparison of drug concentrations in blood and oral fluid collected with the Intercept sampling device. J Anal Toxicol. 2010;34:204-209
12. Patsalos PN, Berry DJ. Therapeutic drug monitoring of antiepileptic drugs by use of saliva. Ther Drug Monit. 2013;35:4-29
13. Schulze H, Schumacher M, Urmeew R, et al. Driving under the influence of drugs, alcohol and medicines in Europe - findings from the DRUID project. In: European Monitoring Centre for Drugs and Drug Addiction. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction; 2012. Available at: Http://www.emcdda.europa.eu/publications/thematicpapers/ druid. Accessed May 27, 2013
14. Ferrara SD, Favretto D, Montisci M, et al. Country report Italy (general traffic). In: Houwing S, Hagenzieker M, Mathijssen R, et al, eds. Prevalence of Alcohol and Other Psychoactive Substances in Drivers in General Traffic. Part II: Country Reports. DRUID Deliverable D 2.2.3. Leidschendam, The Netherlands: SWOV Institute for Road Safety Research; 2011. Available at: Https://biblio.ugent.be/publication/1988588/ file/1988629.pdf. Accessed May 27, 2013
15. Ferrara SD, Favretto D, Montisci M, et al. Country report Italy (killed drivers). In: Isalberti C, van der Linden T, Legrand SA, et al, eds. Prevalence of Alcohol and Other Psychoactive Substances in Injured and Killed Drivers. DRUID Deliverable 2.2.5. Ghent, Belgium: University of Ghent; 2011. Available at: Https://biblio.ugent.be/publication/ 1166367/file/1166392.pdf. Accessed May 27, 2013
16. Vindenes V, Lund HM, Andresen W, et al. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci Int. 2012;219:165-171
17. van der Linden T, Legrand SA, Silverans P, et al. DUID: oral fluid and blood confirmation compared in Belgium. J Anal Toxicol. 2012;36:418-421
18. Langel K, Gunnar T, Ariniemi K, et al. A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:859-870
19. Pehrsson A, Gunnar T, Engblom C, et al. Roadside oral fluid testing: Comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Forensic Sci Int. 2008;175:140-148
20. Swets JA, Dawes RM, Monahan J. Better decisions through science. Sci Am. 2000;283:82-87
21. Fawcett T. An introduction to ROC analysis. Pattern Recogn Lett. 2006; 27:874
22. Langel K, Engblom C, Pehrsson A, et al. Drug testing in oral fluid-evaluation of sample collection devices. J Anal Toxicol. 2008;32:393-401
23. Smink BE, Hofman BJ, Dijkhuizen A, et al. The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam. Br J Clin Pharmacol. 2008;66:556-560
24. de Gier JJ, Hart BJ, Wilderink PF, et al. Comparison of plasma and saliva levels of diazepam. Br J Clin Pharmacol. 1980;10:151-155
25. DiGregorio GJ, Piraino AJ, Ruch E. Diazepam concentrations in parotid saliva, mixed saliva, and plasma. Clin Pharmacol Ther. 1978;24:720-725
26. Kangas L, Allonen H, Lammintausta R, et al. Pharmacokinetics of nitrazepam in saliva and serum after a single oral dose. Acta Pharmacol Toxicol (Copenh). 1979;45:20-24
27. Lund HM, Øiestad EL, Gjerde H, et al. Drugs of abuse in oral fluid collected by two different sample kits - stability testing and validation using ultra performance tandem mass spectrometry analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:3367-3377
28. Robertson MD, Drummer OH. Stability of nitrobenzodiazepines in postmortem blood. J Forensic Sci. 1998;43:5-8
29. Karinen R, Øiestad EL, Andresen W, et al. Comparison of ethanol and other drugs of abuse concentrations in whole blood stored in venoject glass and plastic and venosafe plastic evacuated tubes. J Anal Toxicol. 2010;34:420-428
30. Atanasov VN, Stoykova S, Runiov A, et al. Stability of diazepam in blood samples at different storage conditions and in the presence of alcohol. Forensic Sci Int. 2012;215:159-163
31. Jones AW, Holmgren A, Kugelberg FC. Concentrations of scheduled prescription drugs in blood of impaired drivers: Considerations for interpreting the results. Ther Drug Monit. 2007;29:248-260
32. Welzen M, Uges DR. TIAFT reference blood level list of therapeutic and toxic substances, September 2004. Available at: Http://www.gtfch.org/cms/ images/stories/Updated-TIAFT-list-202005.pdf. Accessed May 27, 2013
33. Skopp G. Preanalytic aspects in postmortem toxicology. Forensic Sci Int. 2004;142:75-100
34. Moffat AC, Jackson JV, Moss MS, et al. Clarke's Isolation and Identification of Drugs. London, United Kingdom: The Pharmaceutical Press; 1986
35. Gjerde H, Øiestad EL, Christophersen AS. Using biological samples in epidemiological research on drugs of abuse. Norsk Epidemiologi. 2011; 21:5-14. Available at: Http://www.ntnu.no/ojs/index.php/norepid/article/ download/1420/1273. Accessed May 27, 2013
36. Gjerde H, Christophersen AS, Normann PT, et al. Associations between substance use and fatal road traffic accidents among car and van drivers in Norway: A case-control study. Transportation Res Part F. 2013;17:134-145
37. Gjerde H, Verstraete AG. Estimating equivalent cutoff thresholds for drugs in blood and oral fluid using prevalence regression: A study of tetrahydrocannabinol and amphetamine. Forensic Sci Int. 2011;212:e26-e30
38. Verstraete A, Knoche A, Jantos R, et al. Per Se Limits - Methods of Defining Cut-off Values for Zero Tolerance. DRUID Deliverable D1.4.2. Ghent, Belgium: Ghent University; 2011. Available at: Https://biblio.ugent.be/ publication/1988464/file/1988490.pdf. Accessed May 27, 2013.